Overview

Gender

male

Dr. Lacroix participated in the launch of the first GeneChem Fund in 1997. He has so far been on the Board of Directors of fifteen companies. Prior to becoming a venture capitalist, Dr. Lacroix, a co-founder of BioChem Pharma Inc. (acquired by Shire Pharmaceuticals Group in 2001), acted as a Director for Technology Transfer at BioChem Pharma. From 1986 to 1995, he held a number of positions with BioChem ImmunoSystems, Inc., including Director, Research and Development and Director, Quality Control. Between 1981 and 1986, Dr. Lacroix was a Professor in the Department of Virology at Institut Armand-Frappier. Dr. Lacroix received a B.Sc. and a M.Sc. in Biochemistry from Université de Montréal and a Ph.D. from the University of Toronto. Dr. Lacroix has authored 33 scientific publications and holds eight issued patents.